Dawnrays Pharmaceutical Holdings Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 608.589 million compared to CNY 488.993 million a year ago. Net income was CNY 166.646 million compared to CNY 129.691 million a year ago. Basic earnings per share from continuing operations was CNY 0.11127 compared to CNY 0.08362 a year ago. Diluted earnings per share from continuing operations was CNY 0.11085 compared to CNY 0.08362 a year ago.